Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer.

MLA

Wen-Yen Huang, et al. “Oral Tegafur-Uracil as Metronomic Therapy Following Intravenous FOLFOX for Stage III Colon Cancer.” PLoS ONE, vol. 12, no. 3, Jan. 2017, p. e0174280. EBSCOhost, https://doi.org/10.1371/journal.pone.0174280.

APA

Wen-Yen Huang, Ching-Liang Ho, Chia-Cheng Lee, Cheng-Wen Hsiao, Chang-Chieh Wu, Shu-Wen Jao, Jen-Fu Yang, Cheng-Hsiang Lo, & Jia-Hong Chen. (2017). Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer. PLoS ONE, 12(3), e0174280. https://doi.org/10.1371/journal.pone.0174280

Chicago

Wen-Yen Huang, Ching-Liang Ho, Chia-Cheng Lee, Cheng-Wen Hsiao, Chang-Chieh Wu, Shu-Wen Jao, Jen-Fu Yang, Cheng-Hsiang Lo, and Jia-Hong Chen. 2017. “Oral Tegafur-Uracil as Metronomic Therapy Following Intravenous FOLFOX for Stage III Colon Cancer.” PLoS ONE 12 (3): e0174280. doi:10.1371/journal.pone.0174280.